Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document C2007/056/64

    Case T-6/07: Action brought on 2 January 2007 — Galderma v OHIM — Lelas (Nanolat)

    ĠU C 56, 10.3.2007, p. 34–34 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, RO, SK, SL, FI, SV)

    10.3.2007   

    EN

    Official Journal of the European Union

    C 56/34


    Action brought on 2 January 2007 — Galderma v OHIM — Lelas (Nanolat)

    (Case T-6/07)

    (2007/C 56/64)

    Language in which the application was lodged: German

    Parties

    Applicant: Galderma SA (Cham, Switzerland) (represented by N. Hebeis, lawyer)

    Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

    Other party to the proceedings before the Board of Appeal of OHIM: Tihomir Lelas

    Form of order sought

    annul the decision of the Fourth Board of Appeal of 25 October 2006 in Case R 0146/2006-4 in so far as the opposition against the goods ‘Pharmaceuticals; pharmaceutical and veterinary products and preparations for health care; soaps; cosmetics and hair lotions’ was rejected;

    refuse Community trade mark application 003088986 NANOLAT for the goods mentioned above;

    order OHIM to pay the costs.

    Pleas in law and main arguments

    Applicant for a Community trade mark: Tihomir Lelas

    Community trade mark concerned: Word mark Nanolat for goods in Classes 1, 3 and 5 (application No 3 088 986)

    Proprietor of the mark or sign cited in the opposition proceedings: The applicant

    Mark or sign cited in opposition: German word mark TANNOLACT for goods in Class 5

    Decision of the Opposition Division: Opposition rejected

    Decision of the Board of Appeal: Appeal dismissed

    Pleas in law: Infringement of Article 8(1)(b) of Regulation (EC) No 40/94, (1) as there is a likelihood of confusion between the opposing marks


    (1)  Council Regulation (EC) No 40/94 of 20 December 1993 on the Community trade mark (OJ L 11, 1994, p. 1).


    Top